WATCH: Tech for health – Amway on its big tech, social commerce, big data ambitions
Amway has identified digital transformation, social commerce, and big data analytics as key in its development of new nutrition products and services.
The company announced in July its partnership with South Korean microbiome start-up Holzapfel Effective Microbes (HEM) in developing personalised probiotics for supporting gut, immune, brain, skin health, as well as weight management.
The at-home microbiome test will be made available in South Korea later this year.
Supplements for Indians: Nutrova to drive clinical trials for existing and upcoming new products
Mumbai-based nutraceutical brand Nutrova is planning to conduct more clinical trials on the Indian population, as it seeks to build its reputation as a scientifically backed industry player.
Axys Nutrition Products, the firm behind Nutrova, received an undisclosed amount of funds from venture capital firm DSG Consumer Partners in June.
Aside from new product development, the funds will be dedicated to conducting clinical trials as the firm hopes to create products that are effective for its target audience – the local Indians between 25 and 45 years old.
Immunity products and China sales a major boost for Swisse-owner H&H as ANZ revenue plunges by a third
Swisse and Biostime owner Health and Happiness (H&H) Group saw demand for immunity products surge, especially in China, as it announced an 8.9% increase in net profit in the first half of this year, despite seeing revenues in Australia and New Zealand plunge by a third.
In its H1 FY2020 announcement, the company said total revenue was RMB$5.16bn (US$748m), up 2.6% compared to the same period last year.
Net profit rose 8.9% to reach RMB$658m (US$95m).
Blackmores 66% profits plunge: Firm refocuses to boost hires in Asia amid 10% jobs cut in ANZ
Blackmores’ top priority now is to tap into strong growth in Asia by shifting some manpower resources from Australia to strategic markets such as China and South East Asia, the company said as it announced a 66.1% drop in net profit on Tuesday (August 25).
In its FY2020 announcement, the company said total global net sales was down 3% yoy to AUD$568m (US$407m).
Net-profit-after-tax (NPAT) nosedived 66.1% yoy to AUD$18.1m (US$12.9m).
Personalised longevity: Hong Kong’s Alixir Life hopes to expand into healthy ageing realm
Hong Kong-based personalised nutrition company Alixir Life is looking to add healthy ageing supplements into its tailored service for consumers, which currently targets 10 different health conditions.
The firm offers a personalised vitamin pack, targeting health concerns including general wellbeing, stress, sleep, focus, skin, joints, digestion, heart, immunity and pregnancy.
Now the company wants to add healthy ageing into the list. Samuel Stitt, founder of Alixir Life told NutraIngredients-Asia: “Ageing itself is starting to be considered as a disease with a convergence of promising research focused on increasing lifespan. There is huge potential to add quality years to our lives, not in just one area but across multiple symptoms of ageing.
